Formally established in 1965, Umeå University is a comprehensive university covering research and education in medicine, science and technology, social sciences, arts and humanities, and educational sciences. Umeå University is also the site of the pioneering discovery of the CRISPR-Cas9 genetic scissors - a revolution in genetic engineering that has been awarded the Nobel Prize in Chemistry.
The Department of Clinical Microbiology at Umeå University conducts research and education in the areas of host microbial interactions, pathogenic properties of microbes, and immune system mechanisms. Within the department there is a stimulating and creative environment for research and education.
Role within NeuroCOV
Umeå University is the host of the research project of Fors Connolly, which will provide data on the national Swedish COVID-19 cohort, and risk factors for receiving a Post-COVID syndrome diagnosis and associated clinical features (using diagnosis codes as proxy). Furthermore, the data will be utilized in collaboration with NeuroCOV's partners, which will enable multi-faceted research projects all focusing on the neurological complications following infection with SARS-CoV-2.
